These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2715780)
21. [The use of Bayes theorum in genetic counseling in cases of Duchenne muscular dystrophy]. Dodinval P J Genet Hum; 1979 Jun; 27(2):131-43. PubMed ID: 541678 [TBL] [Abstract][Full Text] [Related]
22. [Experience with medico-genetic counseling of the families of patients with Duchenne muscular dystrophy]. Krasil'nikov VV; Lazebnik TA; Shilov LA Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(3):338-40. PubMed ID: 3577524 [TBL] [Abstract][Full Text] [Related]
23. [Evaluation of pedigrees explained on the example of progressive muscular dystrophy]. Szibor R; Hemke G; Steinbicker V Z Arztl Fortbild (Jena); 1976 Jan; 70(2):75-8. PubMed ID: 960748 [No Abstract] [Full Text] [Related]
24. [Problems and peculiarities in establishing the genealogical findings and the genetic counseling in hereditary neuromuscular diseases]. Bachmann H; Lössner J Z Gesamte Inn Med; 1981 Jun; 36(11):381-6. PubMed ID: 7303764 [TBL] [Abstract][Full Text] [Related]
29. Genetic counseling in Becker type X-linked muscular dystrophy. II: Practical considerations. Grimm T Am J Med Genet; 1984 Aug; 18(4):719-23. PubMed ID: 6486170 [TBL] [Abstract][Full Text] [Related]
30. Genetic counseling of isolated carriers of Duchenne muscular dystrophy. Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437 [TBL] [Abstract][Full Text] [Related]
31. [Family study allows more optimistic prognosis and genetic counselling in a child with a deletion of exons 50-51 of the dystrophin gene]. Lesca G; Testard H; Streichenberger N; Pelissier JF; Lestra C; Burel E; Jonveaux P; Michel-Calemard L Arch Pediatr; 2007 Mar; 14(3):262-5. PubMed ID: 17258443 [TBL] [Abstract][Full Text] [Related]
33. Possibilities and problems in genomic diagnosis of Duchenne muscular dystrophy with molecular probes. Speer A; Davies K; McGlade S; Hanke R; Spiegler AW; Szibor R; Sommer D; Herrmann F; Coutelle C Biomed Biochim Acta; 1986; 45(7):K19-27. PubMed ID: 2878658 [TBL] [Abstract][Full Text] [Related]
34. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy]. Krasil'nikov VV; Labeznik TA; Shilov LA Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468 [TBL] [Abstract][Full Text] [Related]
35. A molecular approach to genetic counseling in the X-linked muscular dystrophies. Harper PS; Thomas NS Am J Med Genet; 1986 Dec; 25(4):687-702. PubMed ID: 2878617 [TBL] [Abstract][Full Text] [Related]
36. [Epidemiology of progressive muscular dystrophy in selected regions of Poland]. Stepniak U Neurol Neurochir Pol; 1985; 19(5):369-74. PubMed ID: 3831791 [TBL] [Abstract][Full Text] [Related]
37. [New instruments in molecular genetics for the prevention of X chromosome-linked muscular dystrophy]. Ferlini A; Roncuzzi L; Romeo G Minerva Pediatr; 1986 Aug; 38(15-16):639-42. PubMed ID: 3796513 [No Abstract] [Full Text] [Related]